Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning that it mimics the actions of GLP-1 hormone. GLP-1, which is released after eating, slows gastric emptying and enhances insulin secretion to regulate blood glucose. By acting on GLP-1 receptors in the brainβs appetite-control centers, Ozempic additionally reduces hunger and increases feelings of fullness, leading to decreased food intake and weight loss.
verifiedCite
While every effort has been made to follow citation style rules, there may be some discrepancies.
Please refer to the appropriate style manual or other sources if you have any questions.
Select Citation Style